British Columbia has filed a civil claim against JUUL Labs in B.C. Supreme Court, marking the first action under the new Vaping Product Damages and Health Care Costs Recovery Act. The province is seeking to hold the company accountable for harms caused by its products, including youth nicotine addiction and the strain on the public health system.
Officials allege JUUL engaged in deceptive marketing, designing products with highly addictive nicotine salts and youth-friendly flavours that encouraged underage use. The government says these actions prioritized profits over the health of British Columbians.
This legal action follows B.C.’s history of taking on powerful corporations over public health issues. Earlier this year, the province received the first payment of nearly $1 billion from a landmark $3.6-billion tobacco settlement. B.C. is also leading two national class actions against opioid manufacturers, distributors, and consulting firm McKinsey over their roles in the opioid crisis.
The government indicates that other vaping manufacturers and wholesalers may also face civil claims under the VPRA. Officials stress their commitment to holding companies accountable and recovering public health costs associated with preventable harms.
This case highlights the province’s ongoing efforts to ensure corporations are responsible for actions that negatively impact the health and well-being of residents.
Comments